Answers are grounded in this paper and cite their sources.
Craniosynostosis, the premature fusion of cranial sutures, affects approximately 1 in 2,100–2,500 live births and remains exclusively treated by surgery, which carries risks of resynostosis, secondary intracranial hypertension, and neurodevelopmental sequelae. Over the past decade, the cranial suture has been redefined from a passive fibrous joint into a dynamic stem cell niche: mesenchymal stem and progenitor populations marked by Gli1, Axin2, and Prrx1 reside within the suture mesenchyme, sustain calvarial bone homeostasis, and are depleted or dysregulated in craniosynostosis. In parallel, single-cell RNA sequencing, spatial transcriptomics, and single-nucleus epigenomics have produced the first high-resolution atlases of suture development in mouse and human, while machine learning and deep learning methods increasingly shape diagnosis, phenotyping, and data integration. This review synthesizes these converging lines of evidence for a pediatric neurosurgery and regenerative medicine audience. We first describe the cellular and molecular architecture of the suture stem cell niche and its disruption in syndromic and nonsyndromic craniosynostosis. We then review how multi-omics technologies—single-cell transcriptomics, spatial profiling, and chromatin accessibility mapping—are resolving suture cell states, developmental trajectories, and niche interactions, and how artificial intelligence (AI) methods, from variational autoencoders and trajectory inference to gene regulatory network and cell–cell communication models, convert these data into mechanistic hypotheses. We next examine translational progress, including stem cell-based suture regeneration, biomaterial niche engineering, and patient-derived iPSC disease models, and discuss how AI-assisted biomarker discovery, potency prediction, and quality control could support future cell-based interventions. Finally, we outline outstanding challenges—model interpretability, cross-species and cross-dataset transferability, data standards, and the experimental validation of AI-derived predictions—that must be addressed to move toward reliable regenerative strategies for craniosynostosis.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: